CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme-Reference-Cited by-同舟云学术

CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme

Published:2021-04 Issue: Volume:897 Page:173936
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Daniele Simona,La Pietra Valeria^ORCID,Piccarducci Rebecca,Pietrobono Deborah,Cavallini Chiara^ORCID,D'Amore Vincenzo Maria,Cerofolini Linda,Giuntini Stefano,Russomanno Pasquale,Puxeddu Michela^ORCID,Nalli Marianna,Pedrini Martina,Fragai Marco^ORCID,Luchinat Claudio^ORCID,Novellino Ettore,Taliani Sabrina,La Regina Giuseppe^ORCID,Silvestri Romano,Martini Claudia,Marinelli Luciana

Funder

Universita degli Studi di Roma La Sapienza

Università degli Studi di Napoli Federico II

Publisher

Elsevier BV

Subject

Pharmacology

Reference68 articles.

1. Effects of tyrosine kinase inhibitors and CXCR4 antagonist on tumor growth and angiogenesis in rat glioma model: MRI and protein analysis study;Ali;Transl. Oncol.,2013

2. Abstract #1102: CXCR4 activation stimulates MDM2 in a mTOR-dependent manner to promote pancreas tumour growth;Arcarolli;Can. Res.,2009

3. The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling;Berning;Cell Commun. Signal.,2018

4. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival;Bian;Neurosurgery,2007

5. Unravelling mechanisms of p53-mediated tumour suppression;Bieging;Nat. Rev. Canc.,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular, Structural Basis, and Recent Progress for Targeting Murine Double Minute X (MDMX) in Tumors;Journal of Medicinal Chemistry;2024-08-26

2. The story of clobenpropit and CXCR4: can be an effective drug in cancer and autoimmune diseases?;Frontiers in Pharmacology;2024-07-12

3. Study on the design, synthesis, and activity of anti-tumor staple peptides targeting MDM2/MDMX;Frontiers in Chemistry;2024-06-07

4. The CXCR4 might be a potential biomarker for esophageal squamous cell carcinoma: A meta-analysis;Medicine;2024-04-05

5. Development and Nanoparticle-Mediated Delivery of Novel MDM2/MDM4 Heterodimer Peptide Inhibitors to Enhance 5-Fluorouracil Nucleolar Stress in Colorectal Cancer Cells;Journal of Medicinal Chemistry;2024-01-29